Search

Managing Sexual Side Effects After Prostate Cancer: A Patient & Therapist Perspective

@6:00 - 7.15pm

EAU (European Association of Urology) Masterclass on Focal therapy for localised prostate cancer

Focal Therapy (FT) is a promising treatment option aimed at improving the management of localised prostate cancer. This masterclass will provide you with an extensive review of the rationale for FT, the patient selection modalities and the available energy sources (HIFU, Cryo, IRE, Laser, Brachytherapy). Gain further knowledge and better understand the FT benefits.

Prostate Cancer UK: Specialist Education Conference 2025 (Free)

You’ll hear from a panel of expert speakers who’ll share their knowledge and best practice guidance about prostate cancer care. They’ll provide the latest information and guidance, helping you to provide best practice care for your patients. You’ll also cover CPD requirements by attending. From 9am - 12 noon.

RSM (Royal Society of Medicine) Complexity and Complications: Navigating Advanced Prostate Cancer

This year’s RSM Cancer Day will focus on the evolving management of prostate cancer. With emerging evidence supporting radical prostatectomy in oligometastatic disease, the programme will examine patient selection, treatment strategies, and the latest advances for managing advanced-stage cases.

APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025

The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have...

Prostate Cancer UK: Towards Equity: Exploring Prostate Cancer Disparities Experienced by Black Men - data and evidence mini conference (Free)

We will delve into why Prostate Cancer UK is exploring health inequalities, starting with Black men and highlight valuable research findings and challenges in health inequalities space, with keynote speaker Dr Tom Cowling, who will share his insights from the latest England and Wales NPCA State of the Nation Report, including sociodemographic and tumour data from England. From 1.30 pm - 4.30pm

The Royal Marsden: Demystifying the Science Behind Targeted Treatments and Immunotherapies for Prostate, Bladder & Kidney Cancers Study Day

Dr Elaine Vickers will provide an introduction to the science behind a wide variety of targeted therapies and immunotherapies given to people with prostate, bladder and kidney cancer.